DNA RNA and Cells
23 April 2013
ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy23 April 2013
ACT Initiates Higher-Dosage Patient Treatment in European Clinical Trial for Macular Degeneration22 April 2013
TiGenix : Positive Phase IIa Study Results in Refractory Rheumatoid Arthritis With Allogeneic Stem Cell Product Cx61120 April 2013
Aastrom Biosciences Announces First Patients Treated in ixCELL-DCM Clinical Study of ixmyelocel-T18 April 2013
Athersys Announces Authorization of Stem Cell Clinical Trial for Stroke in the United Kingdom17 April 2013
Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amytrophic Lateral Sclerosis15 April 2013
MOLOGEN AG: Skin cancer study with MGN1404 approved12 April 2013
Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation PhaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports